246 related articles for article (PubMed ID: 24607842)
1. JNK signaling mediates EPHA2-dependent tumor cell proliferation, motility, and cancer stem cell-like properties in non-small cell lung cancer.
Song W; Ma Y; Wang J; Brantley-Sieders D; Chen J
Cancer Res; 2014 May; 74(9):2444-54. PubMed ID: 24607842
[TBL] [Abstract][Full Text] [Related]
2. c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells.
Khatlani TS; Wislez M; Sun M; Srinivas H; Iwanaga K; Ma L; Hanna AE; Liu D; Girard L; Kim YH; Pollack JR; Minna JD; Wistuba II; Kurie JM
Oncogene; 2007 Apr; 26(18):2658-66. PubMed ID: 17057737
[TBL] [Abstract][Full Text] [Related]
3. Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC.
Amato KR; Wang S; Hastings AK; Youngblood VM; Santapuram PR; Chen H; Cates JM; Colvin DC; Ye F; Brantley-Sieders DM; Cook RS; Tan L; Gray NS; Chen J
J Clin Invest; 2014 May; 124(5):2037-49. PubMed ID: 24713656
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of microRNA-196a inhibits stem cell self-renewal ability and stemness in non-small-cell lung cancer through upregulating GPX3 expression.
Liu Q; Bai W; Huang F; Tang J; Lin X
Int J Biochem Cell Biol; 2019 Oct; 115():105571. PubMed ID: 31352088
[TBL] [Abstract][Full Text] [Related]
5. ROCK1 knockdown inhibits non-small-cell lung cancer progression by activating the LATS2-JNK signaling pathway.
Xin T; Lv W; Liu D; Jing Y; Hu F
Aging (Albany NY); 2020 Jun; 12(12):12160-12174. PubMed ID: 32554853
[TBL] [Abstract][Full Text] [Related]
6. LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.
Yu L; Chen D; Song J
Thorac Cancer; 2020 Mar; 11(3):603-611. PubMed ID: 31953899
[TBL] [Abstract][Full Text] [Related]
7. Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway.
Shao C; Sullivan JP; Girard L; Augustyn A; Yenerall P; Rodriguez-Canales J; Liu H; Behrens C; Shay JW; Wistuba II; Minna JD
Clin Cancer Res; 2014 Aug; 20(15):4154-66. PubMed ID: 24907115
[TBL] [Abstract][Full Text] [Related]
8. PDIA6 modulates apoptosis and autophagy of non-small cell lung cancer cells via the MAP4K1/JNK signaling pathway.
Bai Y; Liu X; Qi X; Liu X; Peng F; Li H; Fu H; Pei S; Chen L; Chi X; Zhang L; Zhu X; Song Y; Wang Y; Meng S; Jiang T; Shao S
EBioMedicine; 2019 Apr; 42():311-325. PubMed ID: 30922965
[TBL] [Abstract][Full Text] [Related]
9. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
10. Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC.
Wang Z; Ma B; Li H; Xiao X; Zhou W; Liu F; Zhang B; Zhu M; Yang Q; Zeng Y; Sun Y; Sun S; Wang Y; Zhang Y; Weng H; Chen L; Ye M; An X; Liu J
Oncotarget; 2016 Jan; 7(1):509-23. PubMed ID: 26575790
[TBL] [Abstract][Full Text] [Related]
11. Specific role of JNK in the maintenance of the tumor-initiating capacity of A549 human non-small cell lung cancer cells.
Okada M; Shibuya K; Sato A; Seino S; Watanabe E; Suzuki S; Seino M; Kitanaka C
Oncol Rep; 2013 Oct; 30(4):1957-64. PubMed ID: 23912840
[TBL] [Abstract][Full Text] [Related]
12. Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer.
Lee HY; Oh SH; Suh YA; Baek JH; Papadimitrakopoulou V; Huang S; Hong WK
Clin Cancer Res; 2005 Aug; 11(16):6065-74. PubMed ID: 16115952
[TBL] [Abstract][Full Text] [Related]
13. Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling.
Kim IG; Kim SY; Choi SI; Lee JH; Kim KC; Cho EW
Oncogene; 2014 Jul; 33(30):3908-17. PubMed ID: 24013232
[TBL] [Abstract][Full Text] [Related]
14. Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells.
Liu X; Wang L; Cui W; Yuan X; Lin L; Cao Q; Wang N; Li Y; Guo W; Zhang X; Wu C; Yang J
Oncotarget; 2016 Sep; 7(36):58516-58530. PubMed ID: 27542268
[TBL] [Abstract][Full Text] [Related]
15. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.
Jiang F; Qiu Q; Khanna A; Todd NW; Deepak J; Xing L; Wang H; Liu Z; Su Y; Stass SA; Katz RL
Mol Cancer Res; 2009 Mar; 7(3):330-8. PubMed ID: 19276181
[TBL] [Abstract][Full Text] [Related]
16. S897 phosphorylation of EphA2 is indispensable for EphA2-dependent nasopharyngeal carcinoma cell invasion, metastasis and stem properties.
Li JY; Xiao T; Yi HM; Yi H; Feng J; Zhu JF; Huang W; Lu SS; Zhou YH; Li XH; Xiao ZQ
Cancer Lett; 2019 Mar; 444():162-174. PubMed ID: 30583071
[TBL] [Abstract][Full Text] [Related]
17. Requirement of JNK signaling for self-renewal and tumor-initiating capacity of ovarian cancer stem cells.
Seino M; Okada M; Shibuya K; Seino S; Suzuki S; Ohta T; Kurachi H; Kitanaka C
Anticancer Res; 2014 Sep; 34(9):4723-31. PubMed ID: 25202050
[TBL] [Abstract][Full Text] [Related]
18. EphA2 in the early pathogenesis and progression of non-small cell lung cancer.
Brannan JM; Sen B; Saigal B; Prudkin L; Behrens C; Solis L; Dong W; Bekele BN; Wistuba I; Johnson FM
Cancer Prev Res (Phila); 2009 Dec; 2(12):1039-49. PubMed ID: 19934338
[TBL] [Abstract][Full Text] [Related]
19. c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells.
Yoon CH; Kim MJ; Kim RK; Lim EJ; Choi KS; An S; Hwang SG; Kang SG; Suh Y; Park MJ; Lee SJ
Oncogene; 2012 Nov; 31(44):4655-66. PubMed ID: 22249269
[TBL] [Abstract][Full Text] [Related]
20. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM
Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
